Market research
ELMD Electromed, Inc
AMEX USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 334M
- P/E ratio
- 34.44
- Analyst target
- 40.3333
- Dividend yield
- Not available
- Beta
- 0.51
Profile
Company facts
- Exchange
- AMEX
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US2854091087
- Market cap
- 334M
- P/E ratio
- 34.44
- Analyst target
- 40.3333
- Dividend yield
- Not available
- Beta
- 0.51
About
About Electromed, Inc
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ELMD discussion.
5 years, 4 months ago
Electromed, Inc is currently in a long term uptrend where the price is trading 15.3% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.7.
Electromed, Inc's total revenue rose by 11.1% to $9M since the same quarter in the previous year.
Its net income has increased by 1.6% to $1M since the same quarter in the previous year.
Finally, its free cash flow fell by 45.3% to $607K since the same quarter in the previous year.
Based on the above factors, Electromed, Inc gets an overall score of 4/5.